Apoptosis signal-regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension

被引:7
|
作者
Wilson, Kathryn S. [1 ]
Buist, Hanna [1 ]
Suveizdyte, Kornelija [1 ]
Liles, John T. [2 ]
Budas, Grant R. [2 ]
Hughes, Colin [3 ]
MacLean, Margaret R. [1 ]
Johnson, Martin [4 ]
Church, Alistair C. [4 ]
Peacock, Andrew J. [4 ]
Welsh, David J. [1 ,5 ]
机构
[1] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[2] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[3] Univ Glasgow, Cent Res Facil, Glasgow, Lanark, Scotland
[4] Golden Jubilee Natl Hosp, Scottish Pulm Vasc Unit, Clydebank, Scotland
[5] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow, Lanark, Scotland
关键词
pulmonary hypertension; mitogen-activated protein kinases; Sugen; hypoxic rat model; INDUCIBLE FACTOR-I; ACTIVATED PROTEIN-KINASES; ARTERIAL-HYPERTENSION; OXIDATIVE STRESS; MAP KINASE; ADVENTITIAL FIBROBLASTS; THERAPEUTIC TARGETS; ASK1; INHIBITION; P38; MAPK; HYPOXIA;
D O I
10.1177/2045894020922810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary arterial hypertension, group 1 of the pulmonary hypertension disease family, involves pulmonary vascular remodelling, right ventricular dysfunction and cardiac failure. Oxidative stress, through activation of mitogen-activated protein kinases is implicated in these changes. Inhibition of apoptosis signal-regulating kinase 1, an apical mitogen-activated protein kinase, prevented pulmonary arterial hypertension developing in rodent models. Here, we investigate apoptosis signal-regulating kinase 1 in pulmonary arterial hypertension by examining the impact that its inhibition has on the molecular and cellular signalling in established disease. Apoptosis signal-regulating kinase 1 inhibition was investigated in in vivo pulmonary arterial hypertension and in vitro pulmonary hypertension models. In the in vivo model, male Sprague Dawley rats received a single subcutaneous injection of Sugen SU5416 (20 mg/kg) prior to two weeks of hypobaric hypoxia (380 mmHg) followed by three weeks normoxia (Sugen/hypoxic), then animals were either maintained for three weeks on control chow or one containing apoptosis signal-regulating kinase 1 inhibitor (100 mg/kg/day). Cardiovascular measurements were carried out. In the in vitro model, primary cultures of rat pulmonary artery fibroblasts and rat pulmonary artery smooth muscle cells were maintained in hypoxia (5% O-2) and investigated for proliferation, migration and molecular signalling in the presence or absence of apoptosis signal-regulating kinase 1 inhibitor. Sugen/hypoxic animals displayed significant pulmonary arterial hypertension compared to normoxic controls at eight weeks. Apoptosis signal-regulating kinase 1 inhibitor decreased right ventricular systolic pressure to control levels and reduced muscularised vessels in lung tissue. Apoptosis signal-regulating kinase 1 inhibition was found to prevent hypoxia-induced proliferation, migration and cytokine release in rat pulmonary artery fibroblasts and also prevented rat pulmonary artery fibroblast-induced rat pulmonary artery smooth muscle cell migration and proliferation. Apoptosis signal-regulating kinase 1 inhibition reversed pulmonary arterial hypertension in the Sugen/hypoxic rat model. These effects may be a result of intrinsic changes in the signalling of adventitial fibroblast.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Apoptosis Signal-Regulating Kinase 1 Inhibition in Pulmonary Hypertension Too Much to ASK?
    Wilkins, Martin R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (03) : 286 - 288
  • [2] Apoptosis signal-regulating kinase 1 in regulated necrosis
    Hattori, Kazuki
    Ichijo, Hidenori
    CELL CYCLE, 2018, 17 (01) : 5 - 6
  • [3] Apoptosis signal-regulating kinase 1 in stress and immune response
    Takeda, Kohsuke
    Noguchi, Takuya
    Naguro, Isao
    Ichijo, Hidenori
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2008, 48 : 199 - 225
  • [4] Apoptosis signal-regulating kinase 1 as a therapeutic target
    Kawarazaki, Yosuke
    Ichijo, Hidenori
    Naguro, Isao
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (06) : 651 - 664
  • [5] Apoptosis Signal-regulating Kinase 1 promotes Ochratoxin A-induced renal cytotoxicity
    Liang, Rui
    Shen, Xiao Li
    Zhang, Boyang
    Li, Yuzhe
    Xu, Wentao
    Zhao, Changhui
    Luo, YunBo
    Huang, Kunlun
    SCIENTIFIC REPORTS, 2015, 5
  • [6] Targeting apoptosis signal-regulating kinase 1 in acute and chronic kidney disease
    Tesch, Greg H.
    Ma, Frank Y.
    Nikolic-Paterson, David J.
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2020, 303 (10): : 2553 - 2560
  • [7] Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1
    Weijman, Johannes F.
    Kumar, Abhishek
    Jamieson, Sam A.
    King, Chontelle M.
    Caradoc-Davies, Tom T.
    Ledgerwood, Elizabeth C.
    Murphy, James M.
    Mace, Peter D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (11) : E2096 - E2105
  • [8] Regulation and function of apoptosis signal-regulating kinase 1 in rheumatoid arthritis
    Nygaard, Gyrid
    Di Paolo, Julie A.
    Hammaker, Deepa
    Boyle, David L.
    Budas, Grant
    Notte, Gregory T.
    Mikaelian, Igor
    Barry, Vivian
    Firestein, Gary S.
    BIOCHEMICAL PHARMACOLOGY, 2018, 151 : 282 - 290
  • [9] Inhibition of apoptosis signal-regulating kinase 1 enhances endochondral bone formation by increasing chondrocyte survival
    Eaton, G. J.
    Zhang, S.
    Diallo, C.
    Matsuzawa, A.
    Ichijo, H.
    Steinbeck, M. J.
    Freeman, T. A.
    CELL DEATH & DISEASE, 2014, 5 : e1522 - e1522
  • [10] Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain
    Danli Zhou
    Siqi Zhang
    Liang Hu
    Yu-Feng Gu
    Yimei Cai
    Deqin Wu
    Wen-Tao Liu
    Chun-Yi Jiang
    Xiangqing Kong
    Guang-Qin Zhang
    Journal of Neuroinflammation, 16